Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer

Int J Mol Sci. 2023 Apr 14;24(8):7262. doi: 10.3390/ijms24087262.

Abstract

C-X-C motif chemokine ligand 1 (CXCL1) is a member of the CXC chemokine subfamily and a ligand for CXCR2. Its main function in the immune system is the chemoattraction of neutrophils. However, there is a lack of comprehensive reviews summarizing the significance of CXCL1 in cancer processes. To fill this gap, this work describes the clinical significance and participation of CXCL1 in cancer processes in the most important reproductive cancers: breast cancer, cervical cancer, endometrial cancer, ovarian cancer, and prostate cancer. The focus is on both clinical aspects and the significance of CXCL1 in molecular cancer processes. We describe the association of CXCL1 with clinical features of tumors, including prognosis, ER, PR and HER2 status, and TNM stage. We present the molecular contribution of CXCL1 to chemoresistance and radioresistance in selected tumors and its influence on the proliferation, migration, and invasion of tumor cells. Additionally, we present the impact of CXCL1 on the microenvironment of reproductive cancers, including its effect on angiogenesis, recruitment, and function of cancer-associated cells (macrophages, neutrophils, MDSC, and Treg). The article concludes by summarizing the significance of introducing drugs targeting CXCL1. This paper also discusses the significance of ACKR1/DARC in reproductive cancers.

Keywords: CXCL1; breast cancer; cervical cancer; chemokine; endometrial cancer; ovarian cancer; prostate cancer.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms*
  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Chemokine CXCL1 / genetics
  • Clinical Relevance
  • Endometrial Neoplasms* / genetics
  • Female
  • Humans
  • Ligands
  • Male
  • Ovarian Neoplasms*
  • Prostatic Neoplasms*
  • Receptors, Interleukin-8B
  • Tumor Microenvironment
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Ligands
  • Chemokine CXCL1
  • Receptors, Interleukin-8B
  • CXCL1 protein, human

Grants and funding

This study was supported by the statutory budget of the Department of Biochemistry and Medical Chemistry Pomeranian Medical University in Szczecin, Poland.